44 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Eli Lilly Just Succeeded Where Others Failed, but Does It Matter for the Stock? https://www.fool.com/investing/2024/02/10/eli-lilly-just-succeeded-where-others-failed-but-d/?source=iedfolrf0000001 Feb 10, 2024 - Potentially adding billions of dollars in revenue might move the needle for the pharmaceutical giant, but that could take years.
Eli Lilly: Overvaluation Is A Big Red Flag https://seekingalpha.com/article/4669991-eli-lilly-q4-earnings-overvaluation-big-red-flag?source=feed_all_articles Feb 13, 2024 - Eli Lilly has strong financial performance with steady revenue growth and profitability expansion. Find out why LLY stock is a Sell.
Eli Lilly partner BioAge wins $170M to study Zepbound combo https://seekingalpha.com/news/4066258-eli-lilly-partner-bioage-wins-170m-zepbound-combo-study?source=feed_sector_healthcare Feb 13, 2024 - Biotech startup BioAge Labs raises $170M for Phase 2 trials for a combination therapy involving Eli Lilly's Zepbound and other weight loss drugs. Read more here.
Is It Too Late to Buy Eli Lilly Stock Now? https://www.fool.com/investing/2024/03/02/is-it-too-late-to-buy-eli-lilly-stock-now/?source=iedfolrf0000001 Mar 02, 2024 - Eli Lilly stock is having a moment, but the company could easily continue soaring.
The $1T club could soon have its first non-tech members: Berkshire Hathaway & Eli Lilly https://seekingalpha.com/news/4074979-the-1t-club-could-soon-have-its-first-non-tech-members-berkshire-hathaway-eli-lilly?source=feed_sector_healthcare Mar 02, 2024 - Berkshire Hathaway (BRK.A) (BRK.B) & Eli Lilly (LLY) could become the first non-tech companies to hit $1T in market cap. Read more here.
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock. https://www.fool.com/investing/2024/03/09/missed-out-on-eli-lilly-novo-nordisk-this-could/?source=iedfolrf0000001 Mar 09, 2024 - Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.
Elie Hassenfeld Q&A: ‘$5,000 to Save a Life Is a Bargain’ https://www.wired.com/story/elie-hassenfeld-givewell-ea/ Mar 27, 2024 - As Sam Bankman-Fried’s downfall sends effective altruism into a spiral of self-doubt, the idealist quant Elie Hassenfeld is still helping Silicon Valley richies give away hundreds of millions each year.
Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues https://seekingalpha.com/news/4084974-eli-lilly-tops-the-growth-chart-for-the-sp-500-index-in-q1-as-the-sector-gains-momentum?source=feed_sector_healthcare Mar 30, 2024 - The Health Care Select Sector SPDR Fund ETF (XLV) lagged slightly behind the S&P 500 index in Q1 2024, rising 8.31% compared to the overall market's 10.04%...
Eli Lilly launches construction of $2.5B plant to meet obesity drug demand https://seekingalpha.com/news/4088326-eli-lilly-eyes-25b-plant-make-obesity-drugs?source=feed_sector_healthcare Apr 09, 2024 - Eli Lilly (LLY) begins construction of a $2.5B manufacturing plant in Germany to meet demand for its weight loss therapy tirzepatide. Read more here.
Eli Lilly subsidiary, Precision Biosciences end gene therapy collaboration https://seekingalpha.com/news/4090270-eli-lilly-subsidiary-precision-biosciences-end-gene-therapy-collaboration?source=feed_sector_healthcare Apr 16, 2024 - Precision BioSciences (DTIL) said Eli Lilly (LLY) subsidiary Prevail Therapeutics has decided to conclude their gene therapy collaboration. Read more here.

Pages: 12345

<<<Page 3>